Mirae Asset Global Investments’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,373
| Closed | -$422K | – | 2683 |
|
|
2023
Q4 | $422K | Buy |
2,373
+2,139
| +914% | +$381K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $166K | Sell |
234
-33
| -12% | -$23.3K | ﹤0.01% | 2354 |
|
|
2023
Q2 | $1.23M | Sell |
267
-109
| -29% | -$501K | ﹤0.01% | 1451 |
|
|
2023
Q1 | $998K | Buy |
376
+55
| +17% | +$146K | ﹤0.01% | 1548 |
|
|
2022
Q4 | $837K | Sell |
321
-137
| -30% | -$357K | ﹤0.01% | 1587 |
|
|
2022
Q3 | $1.81M | Sell |
458
-213
| -32% | -$843K | ﹤0.01% | 1179 |
|
|
2022
Q2 | $1.75M | Buy |
671
+167
| +33% | +$437K | ﹤0.01% | 1179 |
|
|
2022
Q1 | $1.62M | Buy |
504
+135
| +37% | +$434K | ﹤0.01% | 1212 |
|
|
2021
Q4 | $2.31M | Sell |
369
-11
| -3% | -$68.9K | ﹤0.01% | 1089 |
|
|
2021
Q3 | $3.52M | Sell |
380
-2
| -0.5% | -$18.5K | 0.01% | 951 |
|
|
2021
Q2 | $3.88M | Sell |
382
-110
| -22% | -$1.12M | 0.01% | 879 |
|
|
2021
Q1 | $9.43M | Buy |
+492
| New | +$9.43M | 0.03% | 543 |
|